摘要：
近日, 北京大学药学院药事管理与临床药学系史录文教授/管晓东副教授团队在医学权威期刊柳叶刀·发现科学系列eClinicalMedicine在线发表了题为"Evidence of clinical benefit of WHO essential anticancer medicines for children, 2011–2021" 的最新研究成果。
Supporting:
北京大学药学院. 史录文/管晓东团队在儿童肿瘤基本药物临床获益分析中取得研究进展[J]. 中国药学(英文版), 2023, 32(4): 331-332.
School of Pharmaceutical Sciences, Peking University Health Science Center. The team of Prof. Luwen Shi/Prof. Xiaodong Guan made research progress in the clinical benefit analysis of essential drugs for children cancer[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 331-332.
>
>